+ Site Statistics
References:
54,258,434
Abstracts:
29,560,870
PMIDs:
28,072,757
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Identification of exon skipping events associated with Alzheimer's disease in the human hippocampus



Identification of exon skipping events associated with Alzheimer's disease in the human hippocampus



Bmc Medical Genomics 12(Suppl 1): 13



At least 90% of human genes are alternatively spliced. Alternative splicing has an important function regulating gene expression and miss-splicing can contribute to risk for human diseases, including Alzheimer's disease (AD). We developed a splicing decision model as a molecular mechanism to identify functional exon skipping events and genetic variation affecting alternative splicing on a genome-wide scale by integrating genomics, transcriptomics, and neuroimaging data in a systems biology approach. In this study, we analyzed RNA-Seq data of hippocampus brain tissue from Alzheimer's disease (AD; n = 24) and cognitively normal elderly controls (CN; n = 50) and identified three exon skipping events in two genes (RELN and NOS1) as significantly associated with AD (corrected p-value < 0.05 and fold change > 1.5). Next, we identified single-nucleotide polymorphisms (SNPs) affecting exon skipping events using the splicing decision model and then performed an association analysis of SNPs potentially affecting three exon skipping events with a global cortical measure of amyloid-β deposition measured by [18F] Florbetapir position emission tomography (PET) scan as an AD-related quantitative phenotype. A whole-brain voxel-based analysis was also performed. Two exons in RELN and one exon in NOS1 showed significantly lower expression levels in the AD participants compared to CN participants, suggesting that the exons tend to be skipped more in AD. We also showed the loss of the core protein structure due to the skipped exons using the protein 3D structure analysis. The targeted SNP-based association analysis identified one intronic SNP (rs362771) adjacent to the skipped exon 24 in RELN as significantly associated with cortical amyloid-β levels (corrected p-value < 0.05). This SNP is within the splicing regulatory element, i.e., intronic splicing enhancer. The minor allele of rs362771 conferred decreases in cortical amyloid-β levels in the right temporal and bilateral parietal lobes. Our results suggest that exon skipping events and splicing-affecting SNPs in the human hippocampus may contribute to AD pathogenesis. Integration of multiple omics and neuroimaging data provides insights into possible mechanisms underlying AD pathophysiology through exon skipping and may help identify novel therapeutic targets.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066446579

Download citation: RISBibTeXText

PMID: 30704480

DOI: 10.1186/s12920-018-0453-8


Related references

A compatible exon-exon junction database for the identification of exon skipping events using tandem mass spectrum data. Bmc Bioinformatics 9: 537, 2009

Identification Exon Skipping Events From High-Throughput RNA Sequencing Data. IEEE Transactions on Nanobioscience 14(5): 562-569, 2016

Identification of Splicing Factors Involved in DMD Exon Skipping Events Using an In Vitro RNA Binding Assay. Methods in Molecular Biology 1687: 157-169, 2018

Identification of a human CD36 isoform produced by exon skipping. Conservation of exon organization and pre-mRNA splicing patterns with a CD36 gene family member, CLA-1. Journal of Biological Chemistry 269(8): 6011-6015, 1994

Thousands of exon skipping events differentiate among splicing patterns in sixteen human tissues. F1000research 2: 188, 2014

Genetic variation affecting exon skipping contributes to brain structural atrophy in Alzheimer's disease. AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science 2017: 124-131, 2018

Exon-skipping variants of excitatory amino acid transporter-2 in Alzheimer's disease: Correlation with APOE genotype. 2007

HMGA1a trapping of U1 snRNP at an authentic 5' splice site induces aberrant exon skipping in sporadic Alzheimer's disease. Molecular and Cellular Biology 30(9): 2220-2228, 2010

HMGA1a: sequence-specific RNA-binding factor causing sporadic Alzheimer's disease-linked exon skipping of presenilin-2 pre-mRNA. Genes to Cells 12(10): 1179-1191, 2007

Prediction of single-nucleotide substitutions that result in exon skipping: identification of a splicing silencer in BRCA1 exon 6. Human Mutation 32(4): 436-444, 2011

Identification and partial characterization of a variant of human CXCR3 generated by posttranscriptional exon skipping. Journal of Immunology 173(10): 6234-6240, 2004

Exon 6 skipping in the Fanconi anemia C gene associated with a nonsense/missense mutation (775C-->T) in exon 5: the first example of a nonsense mutation in one exon causing skipping of another downstream. Human Mutation Suppl 1: S25-S27, 1998

Exon 6 skipping in the Fanconi anemia C gene associated with a nonsense/missense mutation in exon 5 The first example of a nonsense mutation in one exon causing skipping of another downstream. Human Mutation 0(SUPPL 1): S25-S27, 1998

Direct Reprogramming of Human DMD Fibroblasts into Myotubes for In Vitro Evaluation of Antisense-Mediated Exon Skipping and Exons 45-55 Skipping Accompanied by Rescue of Dystrophin Expression. Methods in Molecular Biology 1828: 141-150, 2018

TET2 exon 2 skipping is an independent favorable prognostic factor for cytogenetically normal acute myelogenous leukemia (AML): TET2 exon 2 skipping in AML. Leukemia Research 56: 21-28, 2017